FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (48)Camizestrant recommended for breast cancer in EU
Preheader (142)Camizestrant in combination with a CDK4/6 inhibitor recommended for approval in the EU by CHMP for 1st-line advanced ER-positive breast cancer
Arial
Text Analysis
Body Words158
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px788 px
X-Spam Score-0.5
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning
